In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Horizon raises $300mm in senior notes

Executive Summary

Horizon Pharma PLC (orphan, primary care, and rheumatology medicines) raised $300mm in senior notes due 2024. The notes bear an interest rate of 8.75% and will be used along with an existing senior secured credit facility to fund the company's planned acquisition of Raptor Pharmaceutical.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement
    • Nonconvertible Debt

Related Companies

Advertisement
UsernamePublicRestriction

Register